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Today's evolution of robotic pancreatectomy
Not long ago, minimally-invasive pancreatectomy (MIP) did not exist. Many worried it would be too
dangerous, technically unfeasible and even oncologically inadequate. Thankfully, they were wrong and
today many patients are the beneficiaries. But MIP has yet to become mainstream. Why not? Some
point to intrinsic technical limitations, especially for more advanced MIP requiring intestinal recon-
structions. As outlined in a January 2013 HPB review, robotic-assisted MIP is today efficacious, safe
and appealing because of the enhanced dexterity it provides surgeons.Cheng et al. have examined their
recent experience with robotic-assisted middle pancreatectomy (R-MP, n = 7) compared to their open
procedure (O-MP,N=36). Both were equivalent in terms of operative time, blood loss,mortality (zero)
and in general outcomes. Pancreaticogastrostomy was utilized in all R-MP cases, and 5/7 patients
developed Grade B fistulae (O-MP, 5/36 -Grade B fistulae). The overall rates of complications were
similar for R-MP/O-MP, and not surprisingly so were lengths of stay. Figure 1 shows that only 5 trocar
ports were used for R-MP. The authors acknowledge their small case numbers, retrospective design
and selection bias. They do not entertain financial considerations.We can all expect to hear more and
more about robotic pancreatectomy going forward.
Mark Callery
A holistic approach to patients suffering bile duct injury is required
Iatrogenic bile duct injury (BDI) associatedwith cholecystectomy remains a significant embarrassment
to the surgical profession. In this issue of HPB, Landman et al. clearly show that this is a significant
negative life changing event for the affected patient. The authors have performed ameta-analysis of six
publications analysing the long termhealth relatedquality of life (HRQOL) as reportedby suchpatients.
As compared to those patients undergoing uneventful laparoscopic cholecystectomy, patients suffering
BDI were shown to have significantly reduced scores in the mental domains of HRQOL. However,
physical quality of life scores were similar to the control groups once adjusted for time from injury.
Although the likelihood of reduced HRQOL in the mental domains following BDI diminished with
time, it remained a significant independent factor. Patients having suffered a BDI were 38 times more
likely than controls to have significantly lower scores in the mental domains of the HRQOL. What
cannot be determined from this study are the number of BDI patients included for analysis and for
whom the potential physical harm was minimised by early diagnosis, expert treatment and the best
possible management. This would be important information to have since it may be that despite best
management and with only a short period of residual physical deficit, these significant mental disabili-
ties remain. It is also important to note that these reports come from several countries and it is not clear
what systems exist to recognise and acknowledge the injury as well as to support patients mentally and
financially during this stressful time of their lives. Like any good study,manymore questions are raised
but in day to day practice this report behoves the HPB surgeon to approach these patients holistically
and at least enquire of them whether such symptoms remain an issue and refer patients appropriately.
Saxon Connor
Enhanced recovery after liver surgery: a new challenge awaits
I think it is safe to say that enhanced recovery after surgery (ERAS) is here to stay. The majority of
studies that have looked at ERAS protocols of anaesthetic, analgesic and perioperative care refinement
have shown benefit. This benefit also transcends different types of surgery and early successes in
colorectal surgery are being replicated in orthopaedics and other branches of surgery. Liver surgery is
included in this, and both Coolsen et al. fromMaastricht and Connor et al. from Christchurch, provide
evidence of benefit from ERAS programmes. Coolsen et al. undertook a systematic review which
showed reduced length of stay without increased morbidity or mortality from the use of ERAS
programmes. Connor et al., in a single-centre study, also showed reduced length of postoperative stay
among patients treated using ERAS principles although they noted an increased rate of readmissions
in patients as a cost of early discharge. One aspect not dealt with by either study is what I term ‘ERAS
fatigue’.We have noticed in our institution that when we have an ERAS study running admissions are
very short but when the study ends length of stay increases. Behaviours established during the study
slip and old habits are adopted. I am sure that we are not unique. Having established the undoubted
benefits of ERAS protocols it is now a challenge to find ways of embedding these in clinical practice to
ensure that excellent results found in ERAS studies become the routine in day to day HPB surgery.
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